Bayesian Capital Management »

Cytokinetics shares owned by Bayesian Capital Management

Quarter-by-quarter ownership of Cytokinetics (CYTK) shares owned by Bayesian Capital Management from 13F filings

Historical chart of Bayesian Capital Management investment in Cytokinetics

Tip: Access up to 7 years of quarterly data

All positions including Cytokinetics held by Bayesian Capital Management consolidated in one spreadsheet with up to 7 years of data

Download as csvDownload consolidated filings csv Download as ExcelDownload consolidated filings xlsx

Quarterly reported holdings in Cytokinetics by Bayesian Capital Management

Quarter filed Position value Share count Share price at filing
2023-12-31 $3.2M 39k 83.49
2023-03-31 $532k 15k 35.19
2022-12-31 $422k 9.2k 45.82
2022-06-30 $232k 5.9k 39.32
2016-12-31 $159k 13k 12.14